Marshall Wace’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
2,600
+1,500
+136% +$720K ﹤0.01% 2070
2026
Q1
$541K Buy
+1,100
New +$597K ﹤0.01% 2409
2025
Q4
Sell
-1,700
Closed -$825K 3481
2025
Q3
$825K Buy
+1,700
New +$791K ﹤0.01% 2023
2021
Q4
Sell
-31,900
Closed -$18.2M 4275
2021
Q3
$18.2M Buy
+31,900
New +$17.5M 0.08% 295

Other funds holding TMO

Marshall Wace's TMO Position: Q2 2026 in Review

Marshall Wace reduced its Thermo Fisher Scientific (TMO) stake by 99% in Q2 2026, selling an estimated $227M and leaving 4,321 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Marshall Wace first reported a position in TMO in Q1 2014 and has held it in 35 quarters since. The position peaked at $696M in Q4 2021. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Marshall Wace held 4,321 shares of Thermo Fisher Scientific worth $2.17M as of Q2 2026.
  • Marshall Wace sold 472,929 Thermo Fisher Scientific shares in Q2 2026, an estimated $227M.
  • Thermo Fisher Scientific made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1818 holding.
  • Marshall Wace first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 35 quarters since.
  • Marshall Wace's Thermo Fisher Scientific position peaked at $696M in Q4 2021.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.